Evidence map›Paper›PMID 37723250›Full record

ArticleLeukemia2023

Correction: Human CD34

Alison Domingues, Elisa Rossi, Kamila Bujko, Grégoire Detriche, Ulysse Richez, Adeline Blandinieres, Magdalena Kucia, Janina Ratajczak, David M Smadja, Mariusz Z Ratajczak

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Generation of Enucleated Erythrocytes From LinStem cells international · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Alison DominguesStem Cell Biology Program, University of Louisville, Louisville, KY, 40245, USA.
Elisa RossiUniversité de Paris, INSERM, Innovative Therapies in Haemostasis, F-75006, Paris, France.
Kamila BujkoLaboratory of Regenerative Medicine, Medical University of Warsaw, Warsaw, Poland.
Grégoire DetricheUniversité de Paris, INSERM, Innovative Therapies in Haemostasis, F-75006, Paris, France.
Ulysse RichezVascular Medicine Department and Biosurgical Research Lab (Carpentier Foundation), AP-HP, Hôpital Européen Georges Pompidou, F-75015, Paris, France.
Adeline BlandinieresUniversité de Paris, INSERM, Innovative Therapies in Haemostasis, F-75006, Paris, France.
Magdalena KuciaStem Cell Biology Program, University of Louisville, Louisville, KY, 40245, USA.
Janina RatajczakStem Cell Biology Program, University of Louisville, Louisville, KY, 40245, USA.
David M SmadjaUniversité de Paris, INSERM, Innovative Therapies in Haemostasis, F-75006, Paris, France. david.smadja@aphp.fr.ORCID http://orcid.org/0000-0001-7731-9202
Mariusz Z RatajczakStem Cell Biology Program, University of Louisville, Louisville, KY, 40245, USA. mzrata01@louisville.edu.ORCID http://orcid.org/0000-0002-0071-0198

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37723250
PMCPMC10624605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.